Past Events

Events which have already happened.

Using Littered Pack Data to Estimate Cigarette Tax Avoidance in NYC Feb 28, 2013 from 02:00 PM to 03:00 PM 2005 Michael Hooker Bldg.,
David Merriman, Associate Director, Institute of Government and Public Affairs, University of Illinois
Genomics as a tool to improve understanding, prognosis and treatment of breast cancer Feb 27, 2013 from 04:00 PM to 05:00 PM 00-002 Joseph S. Pagano Conference Room, Lineberger,
Katherine “K-T” Varley, Postdoctoral Fellow, HudsonAlpha Institute for Biotechnology
From nano to meso-scale organization of DC-SIGN: a relationship between large scale ordering and dynamics Feb 27, 2013 from 01:30 PM to 02:00 PM 124 Taylor Hall,
Maria Garcia-Parajo, Institute of Photonic Sciences, Barcelona, Spain
Natural and Engineered Protein Cages: Structure, Function, and Frameworks for Synthetic Biology Feb 27, 2013 from 11:00 AM to 12:00 PM 1131 Bioinformatics Building,
Todd Yeates, Professor, University of California at Los Angeles
Structural Basis for the Regulation of GIRK Channel Gating by Soidium, PIP2 and G Proteins Feb 26, 2013 from 04:00 PM to 05:00 PM 1131 Bioinformatics,
Matt Whorton, PhD, Faculty Candidate
Clinical Trial Investigator Series: Finding Funding Through Novartis Feb 26, 2013 from 03:00 PM to 04:30 PM 219 Brinkhous-Bullitt Building,
A Novartis Rep. will be presenting on how clinical trial investigators can gain entrée into Novartis, a pharmaceutical company.
Genetic and Proteomic Identification of E3 Ubiquitin Ligase Substrates Feb 26, 2013 from 12:30 PM to 01:30 PM 00-002 Joseph S. Pagano Conference Room, Lineberger,
Michael J. Emanuele, PhD, Assistant Professor, Department of Pharmacology, Lineberger Comprehensive Cancer Center
Designing Chemically Robust Metal Oxides for Visible-Light Photocatalysis: toward Solar Z-Scheme Water Splitting Feb 26, 2013 from 11:00 AM to 12:00 PM 125 Chapman,
Bart Bartlett, Assistant Professor of Chemistry, University of Michigan
Tissue compartmentalization of immune responses in infection and homeostasis Feb 26, 2013 from 09:30 AM to 10:30 AM 1131 Bioinformatics Building,
Donna L. Farber, Ph.D., Columbia University
Testing for Performance Enhancing Drugs Feb 25, 2013 from 12:30 PM to 01:00 PM 125 Chapman,
Thomas Eisenhart, UNC-CH
The Role of T-Lymphocytes in Salt-Sensitive Hypertension and Renal Damage Feb 25, 2013 from 12:00 PM to 01:00 PM G202 MBRB,
David L. Mattson, PhD, Medical College of Wisconsin
Ion Mobility Spectroscopy Feb 25, 2013 from 12:00 PM to 12:30 PM 125 Chapman,
Leah Heist, UNC-CH
Global Cervical Cancer Prevention: From Research to Implementation Feb 25, 2013 from 09:00 AM to 10:00 AM 0001 BCBS Auditorium, Michael Hooker Research Center,
Jennifer Smith, PhD, Research Associate Professor, Department of Epidemiology, University of North Carolina at Chapel Hill
New Approaches to C–F and C–C Bond Formation by Transition Metal Catalysis Feb 22, 2013 from 12:00 PM to 12:30 PM 125 Chapman,
Abigail Doyle, Assistant Professor of Chemistry, Princeton University
Cluster Crystals and Other Surprises in Flatland Feb 21, 2013 from 04:00 PM to 04:30 PM 125 Chapman,
Zvonimir Dogic, Associate Professor of Physics, Brandeis University
Patient-Centered Outcomes and Comparative Effectiveness Research: It’s History, Current State, and Opportunities Feb 21, 2013 from 03:00 PM to 04:00 PM 00-002 Joseph S. Pagano Conference Room, Lineberger,
Jean R. Slutsky, M.S.P.H., Director, Center for Outcomes and Evidence, Agency for Healthcare Research and Quality
Tobacco Cessation & PCMH: Advances in Evidence-based Treatment Webinar Feb 20, 2013 from 05:00 PM to 06:00 PM Brinkhous-Bullitt Building, Room 219,
Presenters: Adam Goldstein, MD and Carol Ripley-Moffitt, MDiv, CTTS
Metabolomics in exploratory toxicology: Consequences of treatment with the candidate chemopreventive agent pentamethylchromanol (PMCol) Feb 20, 2013 from 02:00 PM to 03:00 PM G-605 Koury ,
Jonathan McDunn, PhD., Associate Director, Diagnostics Research and Development at Metabolomic Inc. and Adjunct Associate Professor of Biomedical Engineering, UNC-Chapel Hill
Metabolomics in exploratory toxicology: Consequences of treatment with the candidate chemopreventive agent pentamethylchromanol (PMCol) Feb 20, 2013 from 02:00 PM to 03:00 PM G605 Koury (1st floor new Dental School Building),
Jonathan McDunn, Ph.D., Associate Director, Diagnostics Research and Development at Metabolomic Inc. & Adjunct Associate Professor, UNC Department of Biomedical Engineering
X-Inactivation as a Paradigm of RNA-Mediated Gene Silencing Feb 19, 2013 from 04:00 PM to 05:00 PM 1131 Bioinformatics,
Joseph M. Calabrese, PhD, Faculty Candidate